Objectives: In Gram-negative bacteria, resistance to b-lactam antibiotics and to known inhibitors mediated by metallo-b-lactamases is a major concern and a serious threat to public health. Since no clinically useful inhibitors are available against class B metallo-b-lactamases, the aim of the study was to identify peptides as inhibitors.
Introduction
Resistance against b-lactam antibiotics is a major problem, mainly caused by the presence of b-lactamases. Class A b-lactamases are susceptible to mechanism-based inhibitors in clinical use but class B enzymes are not. Phage display is a powerful technique for the study of protein-ligand interactions, or to identify peptides as inhibitors of b-lactamase activity. 1 We have previously used this approach with success to identify peptide inhibitors of MurC ATPase and FtsZ GTPase activities. 2, 3 In this study, we used a phage-display technique coupled to a selective biopanning protocol for screening and for identification of peptides having significant inhibition of L-1 metallo-b-lactamase hydrolytic activity.
Materials and methods
Bacterial strains, plasmids and DNA constructions Escherichia coli Novablue (endA1 hsdR17(r 12K À m 12K + ) supE44 thi-1 recA1 gyrA96 relA1 lac [ F 0 proA + B + lacI q ZDM15::Tn10 (TcR)] (Novagen, Madison, WI, USA) was the recipient strain for construction and production of DNA for sequencing. E. coli BL21(lDE3) (F À ompT hsdSB (r b À m b À ) gal dcm (DE3) (Novagen) was the recipient strain for protein expression and purification. The plasmid pMON13 containing blaS coding for class B b-lactamase L-1 from Stenotrophomonas maltophilia GN12873 4 was used to perform PCR cloning. PCR primers containing Nde I-Xho I restriction sites in plasmid pET30a were used to give the plasmid pMON19 coding for a fusion protein L-1 having six histidine residues at the C-terminus. Preparation of DNA and related techniques was by standard methods. 
Phage display
Purified L-1 was used to screen for metallo-b-lactamase peptide inhibitors by phage display using a PH.D.-C-7-C library (New England Biolabs, Mississauga, Ont., Canada) containing $ 3.7 Â 10 9 C-7-C mer random peptide sequences. Biopanning was carried out as described previously 2 except for the following modifications: L-1 was coated on the bottom of a 96-well plate, four rounds of biopanning were performed instead of three and elution in rounds three and four was conducted in two steps-one elution of 5 min followed by a second elution of 30 min, both with 1 mM cefoxitin (Sigma, Oakville, Ont., Canada). Phage recovered after the second elution was used as input for the fourth biopanning. Phage titration, DNA preparation and sequencing of eluted phage after four rounds of biopanning were performed as described previously. 2 Peptide sequences deduced were aligned and a consensus peptide was selected for synthesis. 2 Peptides were synthesized on an ABI 433A Peptide Synthesizer using FastMoc chemistry and purified on a Vydak 22 Â 250 mm C-18 reverse-phase HPLC column using a 0.1% TFA/acetonitrile gradient at 10 mL/min. The dissociation constants (K i competitive and K i uncompetitive ) for the consensus peptide were determined at 30 8C in 50 mM Tris -HCl buffer, pH 8.0, in a 1 mL cuvette reaction volume in a Cary 1 spectrophotometer (Varian, Mississauga, Ont., Canada). Hydrolysis for nitrocefin (Oxford, Mississauga, Ont., Canada) (1 = 17400 M À1 cm
À1
) was monitored at 485 nm. Kinetic constants V max and K m were determined by rates of hydrolysis calculated from the initial velocity in the linear portion, with the same cuvette and a leastsquares calculation. The concentration of L-1 was 20 nM and the five concentrations of nitrocefin tested were 2, 10, 25, 50 and 100 mM with three concentrations of C-7-C peptide at 5, 20, 50 mM, respectively. Hydrolytic activity was measured immediately after mixing reagents. All experiments were carried out in triplicate. Analysis of enzyme kinetic data was carried out using the Leonora software for robust regression analysis of enzyme data and a biweighting regression system. 7 
Results
The S. maltophilia GN12873 L-1 metallo-b-lactamase was purified in milligram quantities to homogeneity. Its six histidine residues were used for this purpose in a single chromatographic step on an affinity nickel column; the mature L-1 molecular mass was confirmed by LC-MS analysis (data not shown).
The purified L-1 enzyme was coated on a microtitre plate and incubated with a phage-display library expressing randomized Cys-(7 amino acids)-Cys peptides. Screening was conducted using four rounds of biopanning; each step included increasingly restrictive conditions of washing and limited time of contact. Competitive elution with cefoxitin was envisaged as a potential tool to identify specific peptides with high affinity for the L-1 active site. After a fourth round of competitive biopanning, DNA sequencing of 17 randomly selected phages and alignment of peptide sequences identified a consensus, repeated eight times, as depicted in Figure 1 . We noted the specific motifSer-Pro-Asn-in the first two peptides, and in the third sequence in the reverse orientation for a total of 13 among 17 peptide sequences.
The peptide Cys-Val-His-Ser-Pro-Asn-Arg-Glu-Cys was synthesized and tested for inhibition of L-1 hydrolytic activity of the chromogenic substrate nitrocefin. The kinetic parameters obtained for L-1 with nitrocefin as substrate are a K m of 15 ± 3 mM, k cat of 24 ± 2 s À1 and with the consensus peptide a K i competitive of 16 ± 4 mM and a K i uncompetitive of 9 ± 1 mM. Activity revealed that the peptide inhibited the hydrolytic activity of L-1 in a mixed inhibition fashion (see Figure 2) . To confirm specificity of L-1 inhibition, we tested a peptide obtained by phage display and known to bind to the capsid of herpes virus (data not shown). Nitrocefin hydrolysis by L-1 in the presence or absence of this peptide gave similar values. Additional testing with BSA (1000-fold) as a competitor did not affect the peptide inhibition observed. We determined the MIC of cefoxitin in the presence of the peptide inhibitor at 2 g/L Figure 1 . Peptide sequences obtained from selected phage clones in phage display. Shown are the peptide sequences selected after four rounds of biopanning, including a competitive biopanning step using cefoxitin. The numbers to the left of the sequences indicate the six peptides selected; the fractions to the right indicate the number of times a specific sequence was identified out of a total of 17 clones selected. The conserved motif identified in 13 sequences is underlined. Abbreviations: E, enzyme; S, substrate; I, inhibitor; P, product; K s dissociation constant of complex enzyme-substrate; K i competitive (K i ), dissociation constant of complex enzymeinhibitor; K i uncompetitive (K i '), dissociation constant of complex enzyme-substrate-inhibitor. using the strains of E. coli and S. maltophilia expressing L-1 b-lactamase. No significant changes in MICs were observed.
The L-1 peptide inhibitor was tested for inhibition of Class A TEM-1 and PSE-4, the Class C P99 and three metallo-b-lactamase-BcII, CphA and FEZ-1. No significant inhibition of the hydrolytic activity of Class A or Class C enzymes was found with nitrocefin as a substrate. In contrast, the L-1 peptide inhibitor diminished the hydrolytic activity of metallo-b-lactamases, such as BcII, by 17% and the CphA enzyme by 25%; the FEZ-1 enzyme was completely inhibited at 100% (data not shown). Curiously, we noted that L-1 and FEZ-1 are in the same subclass-BBL B3-whereas BcII is in BBL B1 and CphA is classified in BBL B in a recent standard numbering scheme. 8 To assess the importance of peptide conformation, the peptide Val-His-Ser-Pro-Asn-Arg-Glu was synthesized without Cys residues and had no significant inhibition of nitrocefin hydrolysis by L-1, even in 1000-fold excess. Hydrolysis of nitrocefin with 20 mM of peptide incubated with L-1 is not affected by the addition of 20 mM ZnCl 2 ; however, we noted that 1000 mM of ZnCl 2 rescued the hydrolytic activity from the peptide inhibitor.
Discussion
In this study, we identified a peptide inhibitor of Class B b-lactamase L-1 and FEZ-1. Using phage display combined with selective biopanning with cefoxitin, we isolated six different peptides. Among the aligned peptide sequences, the Cys-Val-His-Ser-ProAsn-Arg-Glu-Cys was found in $ 50% and the motif Ser-ProAsn was present in 75% of the peptides. Huang and collaborators 1 have used phage display to identify a peptide inhibitor of class A b-lactamase TEM-1; even when using a different b-lactamase, we also obtained a peptide consensus in half the phage isolated. Even though the peptide of Huang et al.
1 is a broadspectrum inhibitor of b-lactamases, no homology was found between their sequence and those reported here. 1 Our biopanning strategies differed mostly by the use of cefoxitin in the elution step in round four. Cefoxitin was chosen for its high affinity for L-1 with a K m of 3.3 mM and its relatively 'slow' hydrolysis with a k cat of 2.2 s À1 , as previously determined. 9 In our selective strategy for biopanning, we expected that cefoxitin would probably compete with phage-displaying peptides competing for the active site of L-1, presumably selecting a peptide inhibitor of hydrolytic activity. Kinetic values with nitrocefin and our recombinant L-1 from S. maltophilia GN12873 were compared with those from L-1 from strain ULA-511 and are similar: a K m of 15 ± 3 mM versus 12 ± 1 mM and a k cat of 24 ± 2 s À1 and 31 ± 2 s À1 , respectively. 9 We noted that the presence or absence of Zn 2+ in the buffer did not change the kinetic constants for hydrolysis of nitrocefin.
The Cys-Val-His-Ser-Pro-Asn-Arg-Glu-Cys peptide gave a mixed inhibition. The apparent affinity of the peptide is almost equal for the enzyme and the enzyme -substrate complex (K i competitive < K i uncompetitive ) at mM concentrations indicating that the behaviour of inhibition is almost purely non-competitive. 10 The peptide Val-His-Ser-Pro-Asn-Arg-Glu had no inhibitory activity suggesting that flanking Cys residues were essential. The TEM-1 consensus peptide, His-Ser-Ala-Cys-AspThr-Arg-Arg-Gly-Asp-Cys-Gly, obtained by phage display was initially found to inhibit very weakly TEM-1 b-lactamase with a K m of $ 3.5 mM. 1 Compared with the L-1 peptide inhibitor, this two-log difference can be explained by differences in biopanning where we used a competitive elution with cefoxitin. We entertain the possibility that competitive biopanning, such as using cefoxitin, is a more promising approach for finding b-lactamase inhibitors. Huang and collaborators 1 suggested that the disulphide bond consensus peptide constrained its conformation and was not optimal for binding and inhibition of TEM-1. For the L-1 peptide inhibitor, we noted that the disulphide bond was essential for its binding and blocking hydrolytic activity. Specific inhibition of Class B L-1 versus Class A TEM-1 and PSE-4, Class C P-99, is not surprising because these enzymes share low sequence identity and have major differences in their active site. Metallo-b-lactamases require zinc, whereas other b-lactamases have a serine protease mechanism. The kinetic data suggested binding of the enzyme and enzyme -substrate complex. The consensus peptide probably binds in the active site region, presumably displacing one of the two Zn atoms essential in the active site for maintaining hydrolytic activity. 11 The peptide inhibitor described here will now be used as a lead compound in peptidomimetics to screen, identify and develop small molecules as inhibitors of class B metallo-b-lactamases.
